Evisa Gjini Bood
About Evisa Gjini Bood
Evisa Gjini Bood is the Associate Director of Translational Research and Mechanisms of Resistance at Bristol-Myers Squibb and a Lead Scientist at Dana-Farber Cancer Institute. She has extensive experience in translational research and pediatrics, with a strong academic background in the Netherlands and the United Kingdom.
Company
Evisa Gjini Bood is currently employed at Bristol-Myers Squibb. She serves as the Associate Director and focuses on Translational Research and Mechanisms of Resistance. Her role is based in Cambridge, Massachusetts, United States, where she has been contributing her expertise since June 2019.
Title
Evisa Gjini Bood holds the title of Associate Director and specializes in Translational Research and Mechanisms of Resistance at Bristol-Myers Squibb. Additionally, she is a Lead Scientist at Dana-Farber Cancer Institute in Boston, Massachusetts, United States.
Education and Expertise
Evisa Gjini Bood has an extensive educational background. She completed her Master of Business Administration at Maastricht School of Management from 2018 to 2020. She also earned a Master of Science in Pharmaceutical Sciences from Utrecht University in the Netherlands, and a bachelor's degree from Universiteit College Utrecht. Her expertise includes translational research, mechanisms of resistance, and pediatrics.
Background
Evisa Gjini Bood has a rich professional background that spans multiple roles and institutions. She worked at Harvard Medical School as an Instructor of Pediatrics for six months in 2015. She was an Adjunct Lecturer at UMass Boston in 2014 for three months. At Dana-Farber Cancer Institute, she held a postdoctoral researcher position from 2010 to 2015, and she also undertook a PhD at Hubrecht Institute from 2005 to 2010. Her experiences further extend to internships at Utrecht University Pharmaceutical Sciences and the University of London.
Achievements
Evisa Gjini Bood has marked significant achievements in her career. Her expertise in translational research and mechanisms of resistance has positioned her as an Associate Director at Bristol-Myers Squibb. She also serves as a Lead Scientist at Dana-Farber Cancer Institute. With a strong background in pediatrics and international academic experience, she has contributed substantially to the scientific community in the United States, the Netherlands, and the United Kingdom.